National and Kapodistrian University of Athens
Μελέτη των δράσεων της βιταμίνης D₃ σε φυσιολογικά και παθολογικά κύτταρα
Abstract
dc:descriptionVitamin D₃ and its analog paricalcitol, are beneficial in human and experimental chronic kidney disease (CKD), the leading cause of which is diabetic nephropathy (DN). Apart from their general efficacy to the treatment of secondary hyperparathyroidism in haemodialysis patients these two molecules also improve the inflammatory status and proteinuria in these patients. In one approach to study the beneficial role of paricalcitol we studied its effects on PAF biosynthesis as well as other inflammatory mediators implicated in CKD. In a separate approach, we used immortalized human podocytes (HGEC) to assess the expression profile of the podocytic-associated proteins podocalyxin and nephrin after treatment with 1,25-dihydroxyvitamin D₃ (calcitriol) and its analogue paricalcitol. In vitro paricalcitol inhibited PAF/thrombin-induced platelet aggregation and the inhibitory effect was comparable with that of PAF/thrombin antagonists. In addition, paricalcitol inhibited in vitro the PAF-CPT activity in platelets and leukocytes and increased PAF-AH activity in leukocytes. However, much higher concentrations of paricalcitol were needed to inhibit λύσο-PAF-AT activity. Similarly, in haemodialysis patients, paricalcitol treatment reduced PAF-CPT activity in platelets and leukocytes and increased PAF-AH activity in leukocytes, while λύσο-PAF-AT activity remained unaltered. On the other hand paricalcitol therapy reduced the expression levels of IL-8, IL-1b, and TNF-a and increased VEGF levels. These results further support the beneficial effects of vitamin D treatment in haemodialysis patients, since it strongly affects PAF/thrombin activities, PAF-metabolism and IL-8, IL-1b, TNF-a and VEGF circulating levels. HGEC exhibit high-glucose-mediated downregulation of podocalyxin and nephrin, loss of which has been linked with loss of the permselective renal barrier and proteinuria. Calcitriol and paricalcitol reversed high glucose-induced decrease of nephrin and significantly enhanced podocalyxin expression in podocytes cultured in high glucose. HGEC express VDR and retinoid X receptor (RXR). In the presence of calcitriol and paricalcitol VDR expression was up-regulated and VDR co-localized with RXR in the nucleus. VDR knock-down abolished the protective action of calcitriol and paricalcitol on podocalyxin expression indicating that podocalyxin activation of expression is partly mediated by VDR. Furthermore VDR specifically regulates podocalyxin expression by bounding to a site upstream of the podocalyxin promoter. Vitamin D analogues maintain and furthermore, re-activate the expression of specialized components of podocytes including podocalyxin, hence they provide protection against loss of the permselective renal barrier, with molecular mechanisms elucidated herein.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Verouti, Sofia
- Βερούτη, Σοφία
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/28570